NEAT1 and breast carcinoma: NEAT1 was the most significantly differentially expressed long non-coding RNA (LncRNA), and its elevated expression has been associated with chemoresistance to cisplatin in various malignant neoplasms, including ovarian cancer [14], medulloblastoma [15], non-small cell lung cancer (NSCLC) [16], and breast cancer [17], among others.